Funding Rounds
Invasight

Invasight Seed (2022, $4M)

Invasight

Clinical biotech firm focused on revolutionizing cell invasion research.

View Company Profile

GET THE TOP 10 COMPANIES OF THE WEEK IN YOUR EMAIL, EVERY TUESDAY.

OR DOWNLOAD OUR DATABASE OF 17,000 COMPANIES →

Summary

Stage: Seed

Raised Amount: $4.67M

Raised Date: 2022-01-01

Investors